Effect of follow-up time on the ability of subcutaneous epcoritamab to induce deep and durable complete remissions in patients with relapsed/refractory large B-cell lymphoma: Updated results from the pivotal EPCORE NHL-1 trial.

TY - JOUR

T1 - Effect of follow-up time on the ability of subcutaneous epcoritamab to induce deep and durable complete remissions in patients with relapsed/refractory large B-cell lymphoma

T2 - Updated results from the pivotal EPCORE NHL-1 trial.

AU - Lunenburg Lymphoma Phase I II

AU - Karimi, Y

AU - Ghesquieres, H

AU - Jurczak, W

AU - Yoon Cheah, Chan

AU - Clausen, Michael Roost

AU - Lugtenburg, P

AU - Cunningham, D

AU - Do, YR

AU - Lewis, DJ

AU - Gasiorowski, R

AU - Kim, TM

AU - Van der Poel, M

AU - Poon, MLM

AU - Feldman, TA

AU - Linton, KM

AU - Sureda, Anna

AU - Hutchings, M

AU - Stirner, MC

AU - Sacchi, M

AU - Thieblemont, Catherine

PY - 2023/6/1

Y1 - 2023/6/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001053772003468&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1200/JCO.2023.41.16_suppl.7525

DO - 10.1200/JCO.2023.41.16_suppl.7525

M3 - Meeting Abstract

SN - 0732-183X

VL - 41

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

ER -